Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:43:27.778Z.
Calculation as of: 2026-10-06T16:43:27.778Z.
Quote observation: 2026-10-06T16:40:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c1ebec02882b5d134f555e456bf3ec52d4d7fba3d3c39a772b469d051cfe6f8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
131.74x
EV/FCF RATIO AVG 3Y
131.74x
EV/FCF RATIO AVG 5Y
55.86x
EV/FCF RATIO AVG 10Y
13.45x
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Seres Therapeutics, Inc.
Market Cap
$27.89M
EV/FCF Ratio
N/A
TTM Avg
131.74x
3Y Avg
131.74x
5Y Avg
55.86x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | $27.89M | N/A | 131.74x | 131.74x | 55.86x |
| InspireMD, Inc. (NSPR)vs › | $28.10M | N/A | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.49M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.41M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.70M | N/A | 3.61x | 3.61x | 3.61x |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.02M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $29.99M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.23M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-05-05 | 119.91x |
| 2026-05-04 | 121.86x |
| 2026-05-01 | 121.04x |
| 2026-04-30 | 118.58x |
| 2026-04-29 | 115.30x |
| 2026-04-28 | 115.71x |
| 2026-04-27 | 118.07x |
| 2026-04-24 | 126.06x |
| 2026-04-23 | 125.96x |
| 2026-04-22 | 129.55x |
| 2026-04-21 | 130.17x |
| 2026-04-20 | 134.68x |
| 2026-04-17 | 134.16x |
| 2026-04-16 | 133.55x |
| 2026-04-15 | 133.65x |
| 2026-04-14 | 131.29x |
| 2026-04-13 | 130.99x |
| 2026-04-10 | 128.32x |
| 2026-04-09 | 132.32x |
| 2026-04-08 | 132.83x |
| 2026-04-07 | 133.75x |
| 2026-04-06 | 133.34x |
| 2026-04-02 | 138.06x |
| 2026-04-01 | 133.86x |
| 2026-03-31 | 133.96x |
| 2026-03-30 | 133.24x |
| 2026-03-27 | 135.29x |
| 2026-03-26 | 138.68x |
| 2026-03-25 | 136.73x |
| 2026-03-24 | 127.91x |
| 2026-03-23 | 131.91x |
| 2026-03-20 | 130.17x |
| 2026-03-19 | 136.11x |
| 2026-03-18 | 135.60x |
| 2026-03-17 | 139.29x |
| 2026-03-16 | 131.81x |
| 2026-03-13 | 131.50x |
| 2022-03-01 | 16.01x |
| 2022-02-28 | 17.77x |
| 2022-02-25 | 18.50x |
| 2022-02-24 | 18.62x |
| 2022-02-23 | 17.16x |
| 2022-02-22 | 18.36x |
| 2022-02-18 | 17.92x |
| 2022-02-17 | 18.42x |
| 2022-02-16 | 19.56x |
| 2022-02-15 | 19.06x |
| 2022-02-14 | 17.48x |
| 2022-02-11 | 18.42x |
| 2022-02-10 | 17.48x |
| 2022-02-09 | 17.62x |
| 2022-02-08 | 16.07x |
| 2022-02-07 | 16.60x |
| 2022-02-04 | 15.95x |
| 2022-02-03 | 16.13x |
| 2022-02-02 | 16.98x |
| 2022-02-01 | 18.65x |
| 2022-01-31 | 18.77x |
| 2022-01-28 | 17.36x |
| 2022-01-27 | 16.10x |
| 2022-01-26 | 16.89x |
| 2022-01-25 | 17.01x |
| 2022-01-24 | 16.34x |
| 2022-01-21 | 16.34x |
| 2022-01-20 | 16.66x |
| 2022-01-19 | 16.51x |
| 2022-01-18 | 15.95x |
| 2022-01-14 | 17.89x |
| 2022-01-13 | 17.13x |
| 2022-01-12 | 17.95x |
| 2022-01-11 | 19.35x |
| 2022-01-10 | 19.06x |
| 2022-01-07 | 19.38x |
| 2022-01-06 | 19.73x |
| 2022-01-05 | 18.27x |
| 2022-01-04 | 19.70x |
| 2022-01-03 | 20.23x |
| 2021-12-31 | 18.74x |
| 2021-12-30 | 19.38x |
| 2021-12-29 | 19.88x |
| 2021-12-28 | 20.03x |
| 2021-12-27 | 20.09x |
| 2021-12-23 | 21.20x |
| 2021-12-22 | 19.53x |
| 2021-12-21 | 19.53x |
| 2021-12-20 | 19.32x |
| 2021-12-17 | 18.68x |
| 2021-12-16 | 18.42x |
| 2021-12-15 | 19.91x |
| 2021-12-14 | 17.95x |
| 2021-12-13 | 18.09x |
| 2021-12-10 | 22.37x |
| 2021-12-09 | 23.19x |
| 2021-12-08 | 23.95x |
| 2021-12-07 | 25.21x |
| 2021-12-06 | 23.69x |
| 2021-12-03 | 25.62x |
| 2021-12-02 | 27.82x |
| 2021-12-01 | 25.80x |
| 2021-11-30 | 25.86x |
| 2021-11-29 | 20.17x |
| 2021-11-26 | 21.73x |
| 2021-11-24 | 22.66x |
| 2021-11-23 | 22.43x |
| 2021-11-22 | 21.20x |
| 2021-11-19 | 21.17x |
| 2021-11-18 | 19.73x |
| 2021-11-17 | 18.97x |
| 2021-11-16 | 18.30x |
| 2021-11-15 | 17.21x |
| 2021-11-12 | 16.95x |
| 2021-11-11 | 16.54x |
| 2017-03-16 | 12.78x |
| 2017-03-15 | 8.99x |
| 2017-03-14 | 8.83x |
| 2017-03-13 | 9.05x |
| 2017-03-10 | 9.05x |
| 2017-03-09 | 9.11x |
| 2017-03-08 | 9.11x |
| 2017-03-07 | 9.01x |
| 2017-03-06 | 9.27x |
| 2017-03-03 | 9.35x |
| 2017-03-02 | 9.53x |
| 2017-03-01 | 9.69x |
| 2017-02-28 | 9.44x |
| 2017-02-27 | 9.47x |
| 2017-02-24 | 8.79x |
| 2017-02-23 | 8.90x |
| 2017-02-22 | 9.08x |
| 2017-02-21 | 9.29x |
| 2017-02-17 | 9.31x |
| 2017-02-16 | 9.39x |
| 2017-02-15 | 9.74x |
| 2017-02-14 | 9.55x |
| 2017-02-13 | 9.35x |
| 2017-02-10 | 9.22x |
| 2017-02-09 | 9.26x |
| 2017-02-08 | 9.01x |
| 2017-02-07 | 9.24x |
| 2017-02-06 | 9.58x |
| 2017-02-03 | 9.54x |
| 2017-02-02 | 9.17x |
| 2017-02-01 | 9.18x |
| 2017-01-31 | 9.67x |
| 2017-01-30 | 9.14x |
| 2017-01-27 | 9.70x |
| 2017-01-26 | 9.67x |
| 2017-01-25 | 9.89x |
| 2017-01-24 | 9.59x |
| 2017-01-23 | 9.63x |
| 2017-01-20 | 9.96x |
| 2017-01-19 | 10.08x |
| 2017-01-18 | 10.32x |
| 2017-01-17 | 10.35x |
| 2017-01-13 | 10.83x |
| 2017-01-12 | 10.66x |
| 2017-01-11 | 10.68x |
| 2017-01-10 | 10.84x |
| 2017-01-09 | 10.89x |
| 2017-01-06 | 11.02x |
| 2017-01-05 | 10.66x |
| 2017-01-04 | 10.88x |
| 2017-01-03 | 9.80x |
| 2016-12-30 | 9.68x |
| 2016-12-29 | 9.77x |
| 2016-12-28 | 9.63x |
| 2016-12-27 | 9.75x |
| 2016-12-23 | 9.98x |
| 2016-12-22 | 9.51x |
| 2016-12-21 | 9.64x |
| 2016-12-20 | 9.89x |
| 2016-12-19 | 9.79x |
| 2016-12-16 | 9.53x |
| 2016-12-15 | 8.91x |
| 2016-12-14 | 8.68x |
| 2016-12-13 | 8.93x |
| 2016-12-12 | 9.17x |
| 2016-12-09 | 9.56x |
| 2016-12-08 | 9.45x |
| 2016-12-07 | 9.55x |
| 2016-12-06 | 10.25x |
| 2016-12-05 | 10.29x |
| 2016-12-02 | 10.14x |
| 2016-12-01 | 9.72x |
| 2016-11-30 | 9.78x |
| 2016-11-29 | 10.11x |
| 2016-11-28 | 10.29x |
| 2016-11-25 | 10.78x |
| 2016-11-23 | 10.96x |
| 2016-11-22 | 10.75x |
| 2016-11-21 | 11.43x |
| 2016-11-18 | 11.59x |
| 2016-11-17 | 11.75x |
| 2016-11-16 | 11.80x |
| 2016-11-15 | 12.45x |
| 2016-11-14 | 12.39x |
| 2016-11-11 | 12.36x |
| 2016-11-10 | 11.50x |
| 2016-11-09 | 9.94x |
| 2016-11-08 | 9.15x |
| 2016-11-07 | 9.35x |
| 2016-11-04 | 8.98x |
| 2016-11-03 | 8.76x |
| 2016-11-02 | 9.12x |
| 2016-11-01 | 9.65x |
| 2016-10-31 | 9.34x |
| 2016-10-28 | 9.73x |
| 2016-10-27 | 10.12x |
| 2016-10-26 | 10.40x |
| 2016-10-25 | 10.68x |
| 2016-10-24 | 10.75x |
| 2016-10-21 | 10.85x |
| 2016-10-20 | 10.89x |
| 2016-10-19 | 10.25x |
| 2016-10-18 | 10.21x |
| 2016-10-17 | 9.89x |
| 2016-10-14 | 9.99x |
| 2016-10-13 | 9.98x |
| 2016-10-12 | 9.56x |
| 2016-10-11 | 9.97x |
| 2016-10-10 | 10.36x |
| 2016-10-07 | 10.07x |
| 2016-10-06 | 9.95x |
| 2016-10-05 | 10.60x |
| 2016-10-04 | 10.26x |
| 2016-10-03 | 10.45x |
| 2016-09-30 | 10.82x |
| 2016-09-29 | 11.20x |
| 2016-09-28 | 11.71x |
| 2016-09-27 | 11.80x |
| 2016-09-26 | 11.53x |
| 2016-09-23 | 11.91x |
| 2016-09-22 | 12.04x |
| 2016-09-21 | 12.85x |
| 2016-09-20 | 12.71x |
| 2016-09-19 | 11.07x |
| 2016-09-16 | 11.11x |
| 2016-09-15 | 11.00x |
| 2016-09-14 | 10.34x |
| 2016-09-13 | 9.93x |
| 2016-09-12 | 9.83x |
| 2016-09-09 | 9.01x |
| 2016-09-08 | 9.71x |
| 2016-09-07 | 9.26x |
| 2016-09-06 | 9.24x |
| 2016-09-02 | 8.70x |
| 2016-09-01 | 8.72x |
| 2016-08-31 | 9.03x |
| 2016-08-30 | 9.36x |
| 2016-08-29 | 9.48x |
| 2016-08-26 | 9.43x |
| 2016-08-25 | 9.22x |
| 2016-08-24 | 9.51x |
| 2016-08-23 | 10.09x |
| 2016-08-22 | 9.94x |
| 2016-08-19 | 9.59x |
| 2016-08-18 | 10.36x |
| 2016-08-17 | 9.96x |
| 2016-08-16 | 9.69x |
| 2016-08-15 | 9.26x |
Showing the most recent 260 of 322 data points. The chart above shows the full history.
